Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9578 posts found.

astrazeneca_plaque

AstraZeneca’s Moventig now available through NHS

October 9, 2015 Medical Communications, Research and Development, Sales and Marketing AstraZeneca, moventig

AstraZeneca has announced that Moventig (naloxegol) has been made available for adult patients with opioid-induced constipation (OIC) in England and …
News
bronchial_thermoplasty

Taking on IFP, COPD and severe asthma: ERS 2015 roundup

October 9, 2015 Medical Communications, Research and Development

Leading pharmaceutical companies, physicians, healthcare professionals, scientists, respiratory experts, and of course the media, including Pharmafocus, gathered in Amsterdam at the …
Feature
Genentech logo

Positive late-stage results for Genentech’s ocrelizumab in different forms of MS

October 8, 2015 Research and Development ECTRIMS, Genentech, MS, Roche, multiple sclerosis, ocrelizumab

Roche’s biotech arm Genentech has presented ‘transformative’ data at an international multiple sclerosis conference on its investigational drug ocrelizumab. Ocrelizumab …
News
obesity

Innovative pipeline can transform obesity treatment, says GBI Research

October 8, 2015 Research and Development obesity

While the current obesity treatment market has a high level of unmet need, the therapeutic landscape could be transformed by …
News
troponin_blood_test

Simple blood test can accurately predict imminent heart attacks

October 8, 2015 Research and Development NHS, heart attack

A simple blood test which predicts whether a patient suffering chest pains will have a heart attack has the potential to save …
News
Gilenya

Novartis looks to new measure of Gilenya outcomes

October 8, 2015 Research and Development fingolimod, gilenya, multiple sclerosis, relapsing multiple sclerosis

Novartis says a new analysis from two Phase III trials reinforces the long-term efficacy profile of its MS treatment Gilenya. …
News

UCB plots new Vimpat submissions after positive monotherapy results

October 8, 2015 Research and Development EMA, European Medicines Agency, UCB, carbamazepine, epilepsy, lacosamide, phase III, vimpat

A Phase III non-inferiority study comparing UCB’s Vimpat with carbamazepine suggests the two drugs can be used as monotherapy treatments.  …
News
Genzyme

Genzyme’s Lemtrada shows five-year efficacy in extended trials

October 8, 2015 Research and Development Genzyme, Lemtrada, MS, RRMS, alemtuzumab, multiple sclerosis, relapsing-remitting multiple sclerosis

Sanofi’s subsidiary Genzyme has achieved positive data from an extension study of Lemtrada in patients with relapsing remitting multiple sclerosis …
News
Nobel Prize

Infectious diseases dominate Nobel Prize awards for medicine

October 8, 2015 Manufacturing and Production, Research and Development Nobel Prize, artemisinin, ivermectin, malaria, mectizan, river blindness

Pharma researchers have been awarded the 2015 Nobel Prize for their work on a river blindness treatment, along with work …
News
ms_symptoms

Multiple Sclerosis treatment will be a $20bn market by 2024

October 7, 2015 Research and Development multiple sclerosis

The value of the multiple sclerosis therapeutics market will rise slowly from $17.2 billion in 2014 to approximately $20 billion …
News
ms_early_intervention

Experts call for greater urgency in MS treatment

October 7, 2015 Research and Development multiple sclerosis

A therapeutic strategy in multiple sclerosis (MS) that aims to maximise lifelong brain health (neurological reserve) needs to be widely …
News
ferring_president

PROFILE: Ambitious Ferring wants to be global fertility leader

October 7, 2015 Manufacturing and Production, Research and Development Ferring, peptides

The stunning view of the Alps across Lake Geneva from Ferring’s corporate headquarters in Saint-Prex seems appropriate for a company …
Feature
amerisourcebergen

AmerisourceBergen acquires sterile compounder PharMEDium for $2.5bn

October 7, 2015 Research and Development, Sales and Marketing AmerisourceBergen, mergers and acquisitions

AmerisourceBergen will now source compounded drugs for its hospital clients by manufacturing them itself after spending more than $2.5 billion …
News
akabia_logo

Akebia passes vadadustat for anaemia phase III study with FDA & EMA

October 7, 2015 Research and Development Akabia, FDA, anaemia

Akebia Therapeutics has announced the successful completion of the End-of-Phase II Meeting process with the FDA and the Scientific Advice …
News
joachim_hoeltz

Rondo AG appoints Joachim Hoeltz as chief exec

October 7, 2015 Manufacturing and Production, Research and Development, Sales and Marketing

Joachim Hoeltz has been appointed chief executive at pharmaceutical packaging company Rondo AG within the Business Area Medipak Systems. He …
Appointment
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026